The CD40–CD40L Dyad in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The CD40–CD40L Dyad in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2017-12-12
DOI
10.3389/fimmu.2017.01791
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Natalizumab Changes the Peripheral Profile of the Th17 Panel in MS Patients: New Mechanisms of Action
- (2018) Rodica Ioana Balasa et al. CNS & Neurological Disorders-Drug Targets
- Decreased serum levels of sCD40L and IL-31 correlate in treated patients with Relapsing-Remitting Multiple Sclerosis
- (2018) José de J. Guerrero-García et al. IMMUNOBIOLOGY
- Soluble CD40 ligand contributes to blood–brain barrier breakdown and central nervous system inflammation in multiple sclerosis and neuromyelitis optica spectrum disorder
- (2017) Hiroki Masuda et al. JOURNAL OF NEUROIMMUNOLOGY
- Inhibition of CD40-TRAF6 interactions by the small molecule inhibitor 6877002 reduces neuroinflammation
- (2017) Suzanne A. B. M. Aarts et al. Journal of Neuroinflammation
- Anti-inflammatory disease-modifying treatment and short-term disability progression in SPMS
- (2017) Johannes Lorscheider et al. NEUROLOGY
- CD40 is a major regulator of dendrite growth from developing excitatory and inhibitory neurons
- (2017) Paulina Carriba et al. eLife
- Th40 cells (CD4+CD40+ Tcells) drive a more severe form of Experimental Autoimmune Encephalomyelitis than conventional CD4 T cells
- (2017) Gisela M. Vaitaitis et al. PLoS One
- Safety concerns and risk management of multiple sclerosis therapies
- (2016) P. Soelberg Sorensen ACTA NEUROLOGICA SCANDINAVICA
- B cells and antibodies in progressive multiple sclerosis: Contribution to neurodegeneration and progression
- (2016) Judith Fraussen et al. AUTOIMMUNITY REVIEWS
- CD40-Mediated NF-κB Activation in B Cells Is Increased in Multiple Sclerosis and Modulated by Therapeutics
- (2016) Ding Chen et al. JOURNAL OF IMMUNOLOGY
- Disease-modifying therapies and infectious risks in multiple sclerosis
- (2016) Alexander Winkelmann et al. Nature Reviews Neurology
- Therapeutic Advances and Future Prospects in Progressive Forms of Multiple Sclerosis
- (2016) Afsaneh Shirani et al. Neurotherapeutics
- B Cells and Autoantibodies in Multiple Sclerosis
- (2015) Anne-Katrin Pröbstel et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Regulatory B Cells and Mechanisms
- (2015) Héctor Rincón-Arévalo et al. INTERNATIONAL REVIEWS OF IMMUNOLOGY
- Discovery of Small Molecule CD40–TRAF6 Inhibitors
- (2015) Barbara Zarzycka et al. Journal of Chemical Information and Modeling
- Targeting and liposomal drug delivery to CD40L expressing T cells for treatment of autoimmune diseases
- (2015) Qian Ding et al. JOURNAL OF CONTROLLED RELEASE
- Activation Status of Human Microglia Is Dependent on Lesion Formation Stage and Remyelination in Multiple Sclerosis
- (2015) Laura A.N. Peferoen et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Role of the innate and adaptive immune responses in the course of multiple sclerosis
- (2015) Bernhard Hemmer et al. LANCET NEUROLOGY
- Longitudinal assessment of immuno-metabolic parameters in multiple sclerosis patients during treatment with glatiramer acetate
- (2015) Pietro B. Carrieri et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
- (2015) James Larkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- The MS Risk Allele of CD40 Is Associated with Reduced Cell-Membrane Bound Expression in Antigen Presenting Cells: Implications for Gene Function
- (2015) Judith Field et al. PLoS One
- Relapse in multiple sclerosis
- (2015) I. Galea et al. BMJ-British Medical Journal
- Relapse in multiple sclerosis
- (2015) I. Galea et al. BMJ-British Medical Journal
- CD8+ T-Cells as Immune Regulators of Multiple Sclerosis
- (2015) Sushmita Sinha et al. Frontiers in Immunology
- Revised diagnostic criteria of multiple sclerosis
- (2014) Ron Milo et al. AUTOIMMUNITY REVIEWS
- Tolerogenic dendritic cells produced by lentiviral-mediated CD40- and interleukin-23p19-specific shRNA can ameliorate experimental autoimmune encephalomyelitis by suppressing T helper type 17 cells
- (2014) T. Kalantari et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Unaltered regulatory B-cell frequency and function in patients with multiple sclerosis
- (2014) Laure Michel et al. CLINICAL IMMUNOLOGY
- Tu1926 Functional Characterization of the CD40 IBD Risk SNP rs6074022: Integrated Gwas, eQTL, and mQTL Defines IBD Patient Subgroups With Altered Pathobiology and Distinct Natural History of Disease
- (2014) Rivkah Gonsky et al. GASTROENTEROLOGY
- Investigation of gene–gene interactions between CD40 and CD40L in Polish multiple sclerosis patients
- (2014) M. Wagner et al. HUMAN IMMUNOLOGY
- Expansion and preferential activation of the CD14+ CD16+ monocyte subset during multiple sclerosis
- (2014) Delgertsetseg Chuluundorj et al. IMMUNOLOGY AND CELL BIOLOGY
- Blocking CD40-TRAF6 interactions by small-molecule inhibitor 6860766 ameliorates the complications of diet-induced obesity in mice
- (2014) S M van den Berg et al. INTERNATIONAL JOURNAL OF OBESITY
- Macrophages migrate in an activation-dependent manner to chemokines involved in neuroinflammation
- (2014) Daphne YS Vogel et al. Journal of Neuroinflammation
- Relationship between metalloproteinase 2 and 9 concentrations and soluble CD154 expression in Iranian patients with multiple sclerosis
- (2014) Javad Sanchooli et al. KAOHSIUNG JOURNAL OF MEDICAL SCIENCES
- Defining the clinical course of multiple sclerosis: The 2013 revisions
- (2014) F. D. Lublin et al. NEUROLOGY
- Blocking CD40-TRAF6 signaling is a therapeutic target in obesity-associated insulin resistance
- (2014) A. Chatzigeorgiou et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Anti-CD40 Ab- or 8-oxo-dG-enhanced Treg cells reduce development of experimental autoimmune encephalomyelitis via down-regulating migration and activation of mast cells
- (2013) Gwan Ui Hong et al. JOURNAL OF NEUROIMMUNOLOGY
- Macrophages in inflammatory multiple sclerosis lesions have an intermediate activation status
- (2013) Daphne YS Vogel et al. Journal of Neuroinflammation
- Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis
- (2013) Ashley H Beecham et al. NATURE GENETICS
- The Brain Microvascular Endothelium Supports T Cell Proliferation and Has Potential for Alloantigen Presentation
- (2013) Julie Wheway et al. PLoS One
- Association of SNPs of CD40 Gene with Multiple Sclerosis in Russians
- (2013) Ekaterina Alekseevna Sokolova et al. PLoS One
- Antibody-independent B cell effector functions in relapsing remitting Multiple Sclerosis: Clues to increased inflammatory and reduced regulatory B cell capacity
- (2012) Sara J. Ireland et al. AUTOIMMUNITY
- CD40–CD40L: Linking pancreatic, adipose tissue and vascular inflammation in type 2 diabetes and its complications
- (2012) Tom Seijkens et al. Diabetes & Vascular Disease Research
- Will the real multiple sclerosis please stand up?
- (2012) Peter K. Stys et al. NATURE REVIEWS NEUROSCIENCE
- Requirement of Transmembrane Domain for CD154 Association to Lipid Rafts and Subsequent Biological Events
- (2012) Nadir Benslimane et al. PLoS One
- Analysis of Proinflammatory and Anti-Inflammatory Cytokine Serum Concentrations in Patients With Multiple Sclerosis by Using a Multiplexed Immunoassay
- (2011) Thomas B. Martins et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Follicular Helper CD4 T Cells (TFH)
- (2011) Shane Crotty Annual Review of Immunology
- Signal pathways in astrocytes activated by cross-talk between of astrocytes and mast cells through CD40-CD40L
- (2011) Dae Kim et al. Journal of Neuroinflammation
- The multiple sclerosis whole blood mRNA transcriptome and genetic associations indicate dysregulation of specific T cell pathways in pathogenesis
- (2010) Kaushal S. Gandhi et al. HUMAN MOLECULAR GENETICS
- Deficient CD40-TRAF6 signaling in leukocytes prevents atherosclerosis by skewing the immune response toward an antiinflammatory profile
- (2010) Esther Lutgens et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Dysregulated neurotrophin mRNA production by immune cells of patients with relapsing remitting multiple sclerosis
- (2010) Nataly Urshansky et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Autoantibody-dependent and autoantibody-independent roles for B cells in systemic lupus erythematosus: Past, present, and future
- (2009) Noam Jacob et al. AUTOIMMUNITY
- Molecular mechanism and function of CD40/CD40L engagement in the immune system
- (2009) Raul Elgueta et al. IMMUNOLOGICAL REVIEWS
- Selective Targeting of B Cells with Agonistic Anti-CD40 Is an Efficacious Strategy for the Generation of Induced Regulatory T2-Like B Cells and for the Suppression of Lupus in MRL/lpr Mice
- (2009) P. A. Blair et al. JOURNAL OF IMMUNOLOGY
- Interferon-β therapy up-regulates BDNF secretion from PBMCs of MS patients through a CD40-dependent mechanism
- (2009) David Azoulay et al. JOURNAL OF NEUROIMMUNOLOGY
- CD40 and autoimmunity: The dark side of a great activator
- (2009) Anna L. Peters et al. SEMINARS IN IMMUNOLOGY
- The immunobiology of CD154–CD40–TRAF interactions in atherosclerosis
- (2009) David Engel et al. SEMINARS IN IMMUNOLOGY
- CD4 T cells: Balancing the coming and going of autoimmune-mediated inflammation in the CNS
- (2008) Bonnie N. Dittel BRAIN BEHAVIOR AND IMMUNITY
- Impact of myelin-specific antigen presenting B cells on T cell activation in multiple sclerosis
- (2008) Christopher T. Harp et al. CLINICAL IMMUNOLOGY
- Low and dysregulated BDNF secretion from immune cells of MS patients is related to reduced neuroprotection
- (2008) David Azoulay et al. JOURNAL OF NEUROIMMUNOLOGY
- Diurnal variation of soluble CD40 ligand in patients with acute coronary syndrome. Soluble CD40 ligand and diurnal variation
- (2008) Alberto Dominguez-Rodriguez et al. THROMBOSIS RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now